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showed that MPV and hs-CRP were independent predictors of clopi-
dogrel resistance in unstable angina pectoris patients.
CONCLUSIONS MPV and hs-CRP were independent predictors of
clopidogrel resistance in patients with unstable angina.
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OBJECTIVES Catestatin is an endogenous multifunctional neuro-
endocrinepeptide. Recently, catestatin was discovered as a novel
angiogenic cytokine. The study was to investigate the associations
between endogenous catestatin and coronary collateral development
among the patients with chronic myocardial ischemia.
METHODS Thirty - eight patients with coronary artery chronic total
occlusions (CTO) (CTO group) and 38 patients with normal coronary
arteries (normal group) were enrolled in series. In the patients with
CTO, coronary collateral development was graded according to the
Rentrop score method. Rentrop score 0-1 collateral development was
regarded as poor collateral group and 2-3 collateral development was
regarded as good collateral group. Plasma catestatin level and
vascular endothelial growth factor (VEGF) were measured by ELISA
kits.
RESULTS The mean serum levels of catestatin in CTO group were
signiﬁcantly higher than that in normal group (1.971.01 vs 1.360.97
ng/ml, p ¼0.009). In the CTO group, The patients with good collateral
development had signiﬁcantly higher catestatin and VEGF levels than
those with poor collateral development (2.360.73 vs 1.611.12 ng/ml,
p ¼0.018; 425.23140.10 vs 238.48101.00 pg/mL, p <0.001). There is
a positive correlation between plasma catestatin levels and Rentrop
score (r ¼0.40, p ¼0.013) among the patients with CTO. However,
there is no correlation between plasma catestatin levels and VEGF (r ¼
-0.06, p ¼0.744). In the multiple linear regression models, plasma
catestatin was one of the independent factors of coronary collateral
development after adjustment for confounders.
CONCLUSIONS The plasma catestatin was associated with coronary
collateral developments. It may be a useful biomarker for coronary
collateral development and potential target for therapeutic angio-
genesis in patients with CTO.
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OBJECTIVES Red cell distribution width (RDW) might be a novel
biomarker that reﬂects multiple physiological impairments related to
atherosclerosis and coronary artery diseases (CAD). We conducted this
systematic review and meta-analysis to evaluate the association of
RDW between all-cause mortality and fatal/non-fatal cardiovascular
disease (CVD) events in CAD patients.
METHODS Relevant studies were searched and identiﬁed in the
MEDLINE and EMBASE databases. English-language prospective
studies that reported risk estimates for RDW and mortality/
CVD events were included. Data were extracted regarding the char-
acteristics and clinical outcomes, and a quality assessment was con-
ducted. Results were extracted for the highest versus lowest RDW
level, and meta-analyses were carried out using random effects
models.
RESULTS We identiﬁed 22 studies enrolling 80,216 participants.
The study duration ranged between 1 month and 23 years. Of the 15
studies that were included in the meta-analysis, higher RDW indi-
cated a signiﬁcant increased risk for all-cause mortality in CAD pa-
tients: pooled risk ratio (RR) 2.20 (95% CI, 1.42-3.39; P<0.0004). The
results for fatal, non-fatal and fatal/non-fatal events were: pooled RR
1.80 (95% CI, 1.35-2.41; P<0.0001), RR 1.86 (95% CI, 1.50-2.31;
P<0.00001) and RR 2.13 (95% CI, 1.20-3.77; P¼0.01). Heterogeneity
was moderately present; however, sensitivity analyses for follow-upduration, CAD subtype, or RDW as dichotomous values showed
similar results.
CONCLUSIONS The meta-analysis indicates that higher RDW levels
are associated with increased risk of mortality and CVD events in
patients with established CAD.
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OBJECTIVES Impaired myocardial reperfusion is associated with
adverse clinical outcomes in patients with ST-segment elevation
myocardial infarction (STEMI). The aim of this study was to investi-
gate the impact of admission mean platelet volume (MPV) on the
myocardial reperfusion and 30-day all-cause mortality in STEMI pa-
tients with successful epicardial coronary reperfusion after primary
percutaneous coronary intervention (PCI).
METHODS A total of 453 STEMI patients who underwent primary PCI
within 12 hours of symptoms onset and achieved TIMI 3 ﬂow at
infarct-related artery (IRA) after PCI were enrolled and divided into
two groups based on postinterventional myocardial blush grade
(MBG): those with MBG 2/3 and those with MBG 0/1. Admission MPV
was measured before coronary angiography. The primary endpoint
was all-cause mortality at 30 days.
RESULTS MPV was signiﬁcantly higher in patients with MBG 0/1 than
in patients with MBG 2/3 (10.380.98 vs 9.590.73, P<0.001). The
cumulative 30-day all-cause mortality rate was signiﬁcantly higher in
the groups with high MPV and MBG 0/1 (6.8% vs 1.5%, P¼0.005, 7.6%
vs 1.9%, P¼0.006, respectively). Multivariate logistic regression
analysis demonstrated MPV was independently associated with
postinterventional impaired myocardial reperfusion (OR 2.668, 95%
CI 2.000 to 3.559, P<0.001) and 30-day all-cause mortality (HR 1.763,
95% CI 1.009 to 3.079, P¼0.046).
CONCLUSIONS Increased MPV at admission is an independent pre-
dictor of impaired myocardial reperfusion and short-term mortality in
STEMI patients with successful epicardial coronary reperfusion after
primary PCI.GW26-e2184
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OBJECTIVES Compelling evidence from large randomized trials
demonstrates the salutary effects of ischemic postconditioning on
cardioprotection against ischemic/reperfusion injury. However,
some studies appear negative ﬁndings. Our objective was to
assess the short- and long-term effects of postconditioning in
patients presenting with evolving ST-elevation myocardial infarc-
tion (STEMI). Relevant studies from were identiﬁed through
electronic.
METHODS Relevant studies from were identiﬁed through electronic
literature search from PubMed, library of congress and EMBASE.
Studies published up to December 2014 were eligible for inclusion.
Patients older than 18 years presenting within 12 h of a ﬁrst STEMI and
eligible for angioplasty were considered for the study. Ischemic
postconditioning was performed by applying consecutive cycles of
reocclusion / reperfusion after reperfusion. The outcome include
infarct size assessed by SPECT or CMR, cardiac biomarkers and left
ventricular ejection fraction (LVEF).
